LUISA
UGEDO URRUELA
Investigador/a en el periodo 1999-2021
CRISTINA
MIGUELEZ PALOMO
PROFESORADO AGREGADO
Publicaciones en las que colabora con CRISTINA MIGUELEZ PALOMO (29)
2022
2021
-
The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats
British Journal of Pharmacology, Vol. 178, Núm. 12, pp. 2516-2532
2020
-
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
British Journal of Pharmacology, Vol. 177, Núm. 17, pp. 3957-3974
-
Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers
Frontiers in Neuroscience, Vol. 14
2019
-
Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats
Experimental Neurology, Vol. 322
-
Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia
International Review of Neurobiology (Academic Press Inc.), pp. 259-279
-
Effects of adult enriched environment on cognition, hippocampal-prefrontal plasticity and NMDAR subunit expression in MK-801-induced schizophrenia model
European Neuropsychopharmacology, Vol. 29, Núm. 5, pp. 590-600
2017
-
Activation of Extracellular Signal-Regulated Kinases (ERK 1/2) in the Locus Coeruleus Contributes to Pain-Related Anxiety in Arthritic Male Rats
International Journal of Neuropsychopharmacology, Vol. 20, Núm. 6, pp. 463-475
-
Impairment of serotonergic transmission by the antiparkinsonian drug L-DOPA: Mechanisms and clinical implications
Frontiers in Cellular Neuroscience
-
Zergatik egiten digu alkoholak kalte?
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 31, pp. 21-32
2016
-
Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors
Experimental Neurology, Vol. 277, pp. 35-45
-
Cannabinoids and Motor Control of the Basal Ganglia: Therapeutic Potential in Movement Disorders
CANNABINOIDS IN HEALTH AND DISEASE (INTECH EUROPE), pp. 59-92
-
Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats
Neurobiology of Disease, Vol. 89, pp. 88-100
-
Cystine/glutamate antiporter blockage induces myelin degeneration
GLIA, Vol. 64, Núm. 8, pp. 1381-1395
-
Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine
Neuropharmacology, Vol. 101, pp. 76-86
-
Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson's disease
Journal of Biomedical Nanotechnology, Vol. 12, Núm. 12, pp. 2220-2230
-
L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo
European Neuropsychopharmacology, Vol. 26, Núm. 8, pp. 1297-1309
-
The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
British Journal of Pharmacology, pp. 2135-2146
2014
-
Altered neuronal activity and differential sensitivity to acute antidepressants of locus coeruleus and dorsal raphe nucleus in Wistar Kyoto rats: A comparative study with Sprague Dawley and Wistar rats
European Neuropsychopharmacology, Vol. 24, Núm. 7, pp. 1112-1122
-
Interaction between the 5-HT system and the basal ganglia: Functional implication and therapeutic perspective in Parkinson's disease
Frontiers in Neural Circuits, Vol. 8, Núm. MAR